Results 271 to 280 of about 2,328,071 (294)

Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings

Ca-A Cancer Journal for Clinicians, 2006
M A McDiarmid, Thomas H Connor
exaly  

Outcome of Combining Epigenetic Drugs With Other Treatments in the Clinic

Medical Epigenetics, 2016
Paromita Raha
exaly  

Food and Drug Administration, Partner in Drug Development

Ca-A Cancer Journal for Clinicians, 2006
Jérôme W Yates, J W Yates
exaly  

Mechanism of Action of Anticancer Drugs at a Cellular Level

Ca-A Cancer Journal for Clinicians, 1968
David A Karnofsky
exaly  

Palliation and Life Prolongation With Anticancer Drugs

Ca-A Cancer Journal for Clinicians, 1966
David A Karnofsky
exaly  

FDA Labeling System for Drugs in Pregnancy

Annals of Pharmacotherapy, 2001
Lisa A Boothby, Paul L Doering
exaly  

Advancing Best Practices for Prescription Drug Labeling

Annals of Pharmacotherapy, 2015
Michael S Wolf, Stacy Cooper Bailey, Heather Black   +2 more
exaly  

Drug Interactions in Cancer Patients Receiving Antidepressants Are Common, Researchers Report

Ca-A Cancer Journal for Clinicians, 2011
Mary Kay Barton
exaly  

A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016)

Value in Health, 2019
Amy Barrett, Ari Gnanasakthy, Emily Evans   +2 more
exaly  

Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective.

JACC Basic To Translational Science, 2018
Issam Zineh
exaly